CUL4B is highly expressed in PCa patients, and miR-101-3p can target CUL4B to inhibit its expression and thus inhibit PCa migration and invasion; this is mediated by inhibiting the PAM signaling pathway (40). The gene discussed is CUL4B; the disease is posterior cortical atrophy.